| Description |
The Clinical Biomarkers Summit will address biomarker translation from preclinical to clinical studies and a variety of biomarker applications in clinical trials, including patient selection, monitoring clinical efficacy and safety, and clinical pharmacology. The Summit also addresses the bridging gap between the pharmaceutical and diagnostics industries and the potential of pharmacogenomics and pharmacodiagnostics. Specific case studies of leveraging biomarkers in accelerating and streamlining clinical trials will offer you a "state-of-the-field" status report.
|
|
